- Efloxate
-
- $41.00 / 10mg
-
2024-11-19
- CAS:119-41-5
- Min. Order:
- Purity: 100%
- Supply Ability: 10g
- Efloxate
-
- $41.00 / 10mg
-
2024-11-19
- CAS:119-41-5
- Min. Order:
- Purity: 100%
- Supply Ability: 10g
- Efloxate
-
- $0.00 / 1KG
-
2020-05-12
- CAS:119-41-5
- Min. Order: 1KG
- Purity: 99.0%
- Supply Ability: 500 MT
|
| efloxate Basic information |
Product Name: | efloxate | Synonyms: | efloxate;EFLOXATE/EFLOXATEM;Corosamin;Domucor;Eflocor;Oxyflavyl;Recordil;2-(4-keto-2-phenyl-chromen-7-yl)oxyacetic acid ethyl ester | CAS: | 119-41-5 | MF: | C19H16O5 | MW: | 324.33 | EINECS: | 204-321-9 | Product Categories: | | Mol File: | 119-41-5.mol |  |
| efloxate Chemical Properties |
Melting point | 123-124° | Boiling point | 382.67°C (rough estimate) | density | 1.1919 (rough estimate) | refractive index | 1.6120 (estimate) | storage temp. | Store at -20°C | solubility | DMSO: 130 mg/mL (400.83 mM) | form | Solid | color | Light yellow to yellow |
Toxicity | LD50 i.p. in rats: 3200 mg/kg (Da Re) |
| efloxate Usage And Synthesis |
Uses | Efloxate (Angorlisin) is a vasodilator used in the research of chronic coronary insufficiency and angina pectoris. Efloxate binds to Staphylococcus aureus sortase A[1]. | Definition | ChEBI: Efloxate is an organic molecular entity. | References | [1] Mahmood Janlou MA, et al. Structure-based virtual screening and molecular dynamics approaches to identify new inhibitors of Staphylococcus aureus sortase A. J Biomol Struct Dyn. 2024 Feb-Mar;42(3):1157-1169. DOI:10.1080/07391102.2023.2201863 |
| efloxate Preparation Products And Raw materials |
|